3-Hydroxy-1-Methylguanine Calcium Sulfide Creatine
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- 3-Hydroxy-1-Methylguanine Calcium Sulfide Creatine
- Multi-Component Homeopathic Formula: Insufficient Evidence for Drug Repurposing Evaluation
Multi-Component Homeopathic Formula: Insufficient Evidence for Drug Repurposing Evaluation
One-Sentence Summary
This submission contains a multi-component formula consisting of six ingredients (3-Hydroxy-1-Methylguanine, Calcium Sulfide, Creatine, Pulsatilla Montana Whole, Sodium Carbonate, and Sulfur), which appears to be a homeopathic compound. The TxGNN model returned no predicted indications for this formula, and the drug has no registered market presence in Taiwan or the United States. As a result, this candidate cannot proceed to standard evaluation without substantial additional data.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | None recorded |
| Predicted New Indication | No prediction available |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction unavailable — no actual studies identified) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |
Why is This Prediction Reasonable?
Currently, detailed mechanism of action data is not available for this multi-component formula. The six components span very different pharmacological categories:
- Creatine and Sodium Carbonate are well-characterised biochemical compounds with established safety profiles in their respective contexts.
- Calcium Sulfide and Sulfur are classical homeopathic/mineral remedy ingredients used in traditional medicine systems.
- Pulsatilla Montana Whole (Pasque Flower) is a botanical used in homeopathic practice, traditionally indicated for conditions including respiratory, gynaecological, and inflammatory disorders.
- 3-Hydroxy-1-Methylguanine is a nucleobase metabolite; its pharmacological role in this combination is unclear.
Because TxGNN operates on individual, DrugBank-mapped drug entities, it cannot generate repurposing predictions for a complex multi-component homeopathic formula that lacks a unified DrugBank ID. Without individual component-level mapping and a defined indication target, mechanistic analysis cannot be completed at this stage.
Clinical Trial Evidence
Currently no related clinical trials registered for this multi-component formula as a unified entity.
Literature Evidence
Currently no related literature available for this specific multi-component combination.
Safety Considerations
Please refer to the package insert for safety information. No DDI data, warnings, or contraindications are currently available for this formula as a combined product.
Conclusion and Next Steps
Decision: Hold
Rationale: The TxGNN model returned no repurposing predictions for this formula, and the compound has no regulatory approval history or DrugBank identifier, making standard evidence-based evaluation impossible at this time.
To proceed, the following is needed:
- Decompose into individual components: Map each of the six ingredients separately to DrugBank IDs and run TxGNN predictions per component.
- Clarify product identity: Confirm whether this is a registered homeopathic product (e.g., a Heel, Weleda, or similar brand formulation) to locate its regulatory dossier.
- Establish original indication: Identify what condition this formula is intended to treat, which is prerequisite for any repurposing analysis.
- MOA documentation: Retrieve mechanism of action for each active ingredient, particularly 3-Hydroxy-1-Methylguanine and Pulsatilla Montana Whole.
- Safety assessment: Collect toxicity, interaction, and contraindication data for each component before any clinical consideration.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.